These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35283690)

  • 21. Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeutics.
    Chen F; Alphonse M; Liu Q
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 May; 12(3):e1609. PubMed ID: 31797562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous gene integration mediated by genome editing technologies in zebrafish.
    Morita H; Taimatsu K; Yanagi K; Kawahara A
    Bioengineered; 2017 May; 8(3):287-295. PubMed ID: 28272984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.
    Dever DP; Porteus MH
    Curr Opin Hematol; 2017 Nov; 24(6):481-488. PubMed ID: 28806273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A CRISPR/Cas9 based polymeric nanoparticles to treat/inhibit microbial infections.
    Verma R; Sahu R; Singh DD; Egbo TE
    Semin Cell Dev Biol; 2019 Dec; 96():44-52. PubMed ID: 30986568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering.
    Wada N; Ueta R; Osakabe Y; Osakabe K
    BMC Plant Biol; 2020 May; 20(1):234. PubMed ID: 32450802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unbiased investigation of specificities of prime editing systems in human cells.
    Kim DY; Moon SB; Ko JH; Kim YS; Kim D
    Nucleic Acids Res; 2020 Oct; 48(18):10576-10589. PubMed ID: 32941652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Delivery Challenge of Genome Editing in Human Epithelia.
    Calderón M; Hedtrich S
    Adv Healthc Mater; 2021 Oct; 10(19):e2100847. PubMed ID: 34165913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas systems: opportunities and challenges for crop breeding.
    Biswas S; Zhang D; Shi J
    Plant Cell Rep; 2021 Jun; 40(6):979-998. PubMed ID: 33977326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR/Cas9 Editing: Sparking Discussion on Safety in Light of the Need for New Therapeutics.
    Carlaw TM; Zhang LH; Ross CJD
    Hum Gene Ther; 2020 Aug; 31(15-16):794-807. PubMed ID: 32586150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Plant prime editing technique: a new genome editing tool for plants].
    DU Q; Wang C; Liu G; Zhang D; Zhang S; Qiu J
    Sheng Wu Gong Cheng Xue Bao; 2022 Jan; 38(1):26-33. PubMed ID: 35142116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR-dCas9 Mediated Cytosine Deaminase Base Editing in
    Yu S; Price MA; Wang Y; Liu Y; Guo Y; Ni X; Rosser SJ; Bi C; Wang M
    ACS Synth Biol; 2020 Jul; 9(7):1781-1789. PubMed ID: 32551562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of CRISPR/Cas9 for therapeutic genome editing.
    Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
    J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-Specific Integration of Exogenous Genes Using Genome Editing Technologies in Zebrafish.
    Kawahara A; Hisano Y; Ota S; Taimatsu K
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
    Dong W; Kantor B
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly efficient DNA-free plant genome editing using virally delivered CRISPR-Cas9.
    Ma X; Zhang X; Liu H; Li Z
    Nat Plants; 2020 Jul; 6(7):773-779. PubMed ID: 32601419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
    Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
    Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using "Good-Fit" Genome-Editing Tools.
    Kim U; Kim N; Shin HY
    Cells; 2020 Dec; 9(12):. PubMed ID: 33271878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.